metricas
covid
Buscar en
Revista de Psiquiatría y Salud Mental (English Edition)
Toda la web
Inicio Revista de Psiquiatría y Salud Mental (English Edition) Psychometric performance of the Oviedo Sleep Questionnaire in patients with seve...
Información de la revista
Vol. 2. Núm. 4.
Páginas 169-177 (enero 2009)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 2. Núm. 4.
Páginas 169-177 (enero 2009)
Original
Acceso a texto completo
Psychometric performance of the Oviedo Sleep Questionnaire in patients with severe mental disorder
Rendimiento psicométrico del Cuestionario Oviedo de Sueño en pacientes con trastorno mental grave
Visitas
1459
M. Paz García-Portillaa,
Autor para correspondencia
albert@uniovi.es

Corresponding author.
, Pilar Alejandra Sáiza, Eva M. Díaz-Mesaa, Eduardo Fonsecab, Manuel Arrojoc, Pilar Sierrad, Fernando Sarrameae, Emilio Sánchezf, José Manuel Goikoleag, Vicent Balanzáh, Antonio Benabarreg, Julio Bobesa
a Department of Psychiatry, University of Oviedo, Asturias, Biomedical Research Network Centre of Mental Health (CIBERSAM), Spain
b Department of Personality, Evaluation and Treatment, University of Oviedo, Asturias, Biomedical Research Network Centre of Mental Health (CIBERSAM), Spain
c University Hospital Complex of Santiago de Compostela, Santiago de Compostela, A Coruña, Spain
d La Fe University Hospital, Valencia, Spain
e Jaén Norte Health District, Andalusian Health Service, Jaén, Spain
f Gregorio Marañón University General Hospital, Madrid, Centro de Investigación Biomédica en Salud Mental, CIBERSAM, Spain
g Hospital Clínic, Barcelona, Biomedical Research Network Centre of Mental Health (CIBERSAM), Spain
h Catarroja Mental Health Centre, Valencia, Biomedical Research Network Centre of Mental Health (CIBERSAM), Spain
Este artículo ha recibido
Información del artículo
Abstract
Introduction

The prevalence of sleep disturbances among patients with severe mental disorder ranges from 30 to 80%. Since the impact of these disturbances on patients’ lives is substantial, there is a need for their evaluation and management. The aim of this study was to examine the reliability and validity of the Oviedo Sleep Questionnaire (OSQ) in patients with severe mental disorder.

Material and methods

We performed an observational, prospective (3-month), multicenter study. A total of 259 individuals (184 patients with severe mental disorder and 75 controls) were included. Evaluation: the OSQ, the sleep items of the Bech-Rafaelsen's Scales for Depression (MES item 3) and Mania (MAS item 5), and the Clinical Global Impression Scales for Severity of Mental Disorder (CGI-SMD) and Sleep Disorder (CGI-SSD).

Results

a) Factorial structure: two factors accounted for 57.65% of the variance; factor 1 (insomnia) accounted for 44.65% and factor 2 (hypersomnia) for 13%; b) internal consistency: total OSQ=0.90, insomnia scale=0.91, hypersomnia scale=0.88; c) testretest reliability=0.87; d) convergent validity: Pearson's correlation coefficients were 0.632 with item 3 of the MES, 0.619 with item 5 of the MAS, and 0.630 with the CGI-SS (p<0.001); e) discriminant validity: the OSQ was able to differentiate between patients and controls (p=0.018), and among distinct degrees of mental disorder severity (CGISMD) (p<0.001) and sleep disorder severity (CGI-SSD) (p<0.001); f) responsiveness: the OSQ, like the CGI-SSD (p=0.004), identified a significant decrease in the insomnia severity score after 3 months (p=0.005).

Conclusions

The OSQ is a valid and reliable method for measuring the sleep/wake cycle in patients with severe mental disorder.

Keywords:
Oviedo Sleep Questionnaire
Insomnia
Hypersomnia
Schizophrenia
Bipolar disorder
Resumen
Introducción

El 30–80% de los pacientes con trastorno mental grave manifiestan dificultades del sueño. Su impacto es especialmente significativo en ellos por lo que su evaluación y su manejo resultan obligados. El objetivo fue examinar la fiabilidad y validez del Cuestionario Oviedo de Sueño (COS) en pacientes con trastorno mental grave.

Material y métodos

Estudio observacional, prospectivo (3 meses), multicéntrico. Participaron 259 sujetos (184 con trastorno mental grave y 75 como controles). Evaluación: COS, ítems del sueño de las Escalas de Bech-Rafaelsen para Depresión (MES, ítem 3) y para Manía (MAS, ítem 5), escalas de Impresión Clínica Global de Gravedad del Trastorno Mental (ICG-GTM) y del Trastorno del Sueño (ICG-GTS).

Resultados

a) Estructura factorial: dos factores que explican el 57,65% de la variancia; el factor 1, insomnio, explica el 44,65% y el 2, hipersomnio, el 13%; b) consistencia interna: COS total=0,90, escala insomnio=0,91, escala hipersomnio=0,88; c) fiabilidad test-retest, 0,87; d) validadez convergente: coeficiente de correlación de Pearson con ítem 3 MES=0,632, con ítem 5 MAS=0,619, y con ICG-GTS=0,630 (p<0,001); e) validez discriminante: discriminó entre pacientes y controles (p=0,018), y entre distintos grados de gravedad del trastorno mental (ICG-GTM) (p<0,001) y del trastorno del sueño (ICGGTS) (p<0,001), y f) sensibilidad a los cambios: detectó disminución significativa de la gravedad del insomnio a los 3 meses (p=0,005) al igual que la ICG-GTS (p=0,004).

Conclusiones

El COS es un instrumento de medida del ritmo sueño-vigilia válido y fiable en los pacientes con trastorno mental grave.

Palabras clave:
Cuestionario Oviedo de Sueño
Insomnio
Hipersomnio
Esquizofrenia
Trastorno bipolar
El Texto completo está disponible en PDF
References
[1.]
E.O. Bixler, A. Kales, C.R. Soldatos, J.D. Kales, S. Healey.
Prevalence of sleep disorders in the Los Angeles metropolitan area.
Am J Psychiatry, 136 (1979), pp. 1257-1262
[2.]
S. Cohrs.
Sleep disturbances in patients with schizophrenia: impact and effect of antipsychotics.
CNS Drugs, 22 (2008), pp. 939-962
[3.]
A.N. Vgontzas, D. Liao, S. Pejovic, S. Calhoun, M. Karatarki, E.O. Bixler.
Insomnia with objective short sleep duration is associated with type 2 diabetes: A population-based study.
Diabetes Care, (2009),
[4.]
K. Spiegel.
Sleep loss as a risk factor for obesity and diabetes.
Int J Pediatr Obes, 3 (2008), pp. 27-28
[5.]
A.N. Vgontzas, D. Liao, E.O. Bixler, G.P. Chrousos, A. Vela-Bueno.
Insomnia with objective short sleep duration is associated with a high risk for hypertension.
Sleep, 32 (2009), pp. 491-497
[6.]
L.M.F. Giglio, A.C. Andreazza, M. Andersen, K.M. Cersér, J.C. Walz, L. Sterz, et al.
Sleep in bipolar patients.
Sleep Breath, 13 (2009), pp. 169-173
[7.]
A.D. Krystal, M. Thakur, T. Roth.
Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia.
Ann Clin Psychiatry, 20 (2008), pp. 39-46
[8.]
Y.-T. Xiang, Y.-Z. Weng, C.-M. Leung, W.-K. Tang, K.Y.C. Lai, G.S. Ungvari.
Prevalence and correlates of insomnia and its impact on quality of life in Chinese schizophrenia patients.
Sleep, 32 (2009), pp. 105-109
[9.]
B. Sivertsen, S. Krokstad, S. Overland, A. Mykletun.
The epidemiology of insomnia: Associations with physical and mental health. The HUNT-2 study.
J Psychosom Res, 67 (2009), pp. 109-116
[10.]
T. Roth.
Prevalence, associated risks, and treatment patterns of insomnia.
J clin Psychiatry, 66 (2005), pp. 10-13
[11.]
D. Leger, C. Guilleminault, G. Bader, E. Levy, M. Pailard.
Medical and socio-professional impact of insomnia.
Sleep, 25 (2002), pp. 625-629
[12.]
F. Sagberg.
Driver health and crash involvement: A case-control study.
Accid Anal Prev, 38 (2006), pp. 28-34
[13.]
M. Daley, C.M. Morin, M. LeBlanc, J.P. Grégoire, J. Savard.
The economic burden of insomnia: Direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers.
Sleep, 32 (2009), pp. 55-64
[14.]
M. Pompili, D. Lester, A. Grispini, M. Innamorati, F. Calndro, P. Iliceto, et al.
Completed suicide in schizophrenia: Evidence from a case-control study.
Psychiatry Res, 167 (2009), pp. 251-257
[15.]
M. Bauer, T. Glenn, P. Grof, N. Rasgon, M. Alda, W. Marsh, et al.
comparison of sleep/wake parameters for self-monitoring bipolar disorder.
J Affect Disord, 116 (2009), pp. 170-175
[16.]
T. Roth, S. Jaeger, A. Kalsekar, P.E. Stang, R.C. Kessler.
Sleep problems, comorbid mental disorders, and role functioning in the National Comorbidity Survey Replication.
Biol Psychiatry, 60 (2006), pp. 1364-1371
[17.]
D.J. Buysse, C.F. Reynolds, T.H. Monk, S.R. Berman, D.J. Kupfer.
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.
Psychiatry Res, 28 (1989), pp. 193-213
[18.]
J.A. Macías, A. Royuela.
La versión española del Índice de Calidad de Sueño de Pittsburgh.
Informaciones Psiquiátricas, 146 (1996), pp. 465-472
[19.]
R.D. Hays, S.A. Martin, A.M. Sesti, K.L. Spritzer.
Psychometric properties of the Medical Outcomes Study Sleep measure.
[20.]
J. Rejas, M.V. Ribera, M. Ruiz, X. Masrramón.
Psychometric properties of the MOS (Medical Outcomes Study) Sleep Scale in patients with neuropathic pain.
Eur J Pain, 11 (2007), pp. 329-340
[21.]
J. Bobes, M.P. González, P.A. Sáiz, M.T. Bascarán, C. Iglesias, J.M. Fernández.
Propiedades psicométricas del cuestionario Oviedo de sueño.
Psicothema, 12 (2000), pp. 107-112
[22.]
E. Vieta, J. Bobes, J. Ballesteros, A. González-Pinto, A. Luque, N. Ibarra, et al.
Validity and reliability of the Spanish versions of the Bech-Rafaelsen's mania and melancholia scales for bipolar disorders.
Acta Psychiatr Scand, 117 (2008), pp. 207-215
[23.]
W. Guy.
Early Clinical Drug Evaluation (ECDEU) Assessment Manual.
National Institute of Mental Health, (1976),
[24.]
U. Lorenzo-Seva, P.J. Ferrando.
FACTOR: A computer program to fit the exploratoy factor analysis model.
Behav Res Meth, Instrum Comput, 38 (2006), pp. 88-91
[25.]
K.G. Jöreskorg, D. Sörbom.
LISREL 8 user's reference guide.
Scientific Software International, (1993),
[26.]
P. Elosúa, B.D. Zumbo.
Coeficientes de fiabilidad para escalas de respuesta ordenada.
Psicothema, 20 (2008), pp. 896-901
Copyright © 2009. SEP y SEPB
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos